Literature DB >> 28471569

Concomitant Treatment with Ibrutinib and Amiodarone Causing Reversible Heart Failure Syndrome.

Yishay Wasserstrum1,2, Pia Raanani3,2, Ran Kornowski1,2, Zaza Iakobishvili1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28471569

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  1 in total

1.  Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy.

Authors:  Misbahuddin Khaja; Hitesh Gurjar; Laura Yapor; Minu C Abraham; Nolberto Hernandez; Asim Haider
Journal:  Cureus       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.